ICMRA Review Finds Remote Alternatives Could Complement Onsite Inspections, Not Replace Them

Remote inspections may be handy when the pandemic prevents travel, but they are no substitute for onsite inspections, especially when detailed observations are required, the International Coalition of Medicines Regulatory Authorities has concluded.

A 13 December policy paper that a working group in ICMRA’s COVID-19 group wrote found that while remote inspections are “an enabling tool to maintain at least a minimal regulatory...